The companies entered into a definitive agreement for the $4.9 billion acquisition in January. The deal will support Stryker’s neurovascular business.
Inari was founded in 2011 and makes products for VTE clot removal without thrombolytic drugs.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
